Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments.
Martínez-López-de-Castro N, Samartín-Ucha M, Paradela-Carreiro A, Pérez-Landeiro A, Inaraja-Bobo MT, Álvarez-Payero M, Castro-Núñez I, García-Beloso N, Robles-Torres D, López-López A, González-Costas S, Leboreiro-Enríquez B, Otero-Millán L, Yaiza Romero-Ventosa E, Casanova-Martínez C, Lorenzo-Lorenzo K, Regueira-Arcay AM, Vázquez-López C, Martínez-Reglero C, Piñeiro-Corrales G.
Martínez-López-de-Castro N, et al. Among authors: vazquez lopez c.
J Clin Pharm Ther. 2021 Jun;46(3):724-730. doi: 10.1111/jcpt.13337. Epub 2020 Dec 23.
J Clin Pharm Ther. 2021.
PMID: 33368439